Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation - Wikidata - awgldk - TriplyDB

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation

http://www.wikidata.org/entity/Q34682171

about

Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.Lessons from acute HIV infection.HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation Tryptophan catabolism and immune activation in primary and chronic HIV infection Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells Microbial translocation and microbiome dysbiosis in HIV-associated immune activation Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes.Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin.CD4(+) T Follicular Helper and IgA(+) B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification.The HIV treatment cascade in acutely infected people: informing global guidelines.HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients.Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection Cancer prevention in HIV-infected populations.Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports.Strategies to target non-T-cell HIV reservoirs Impact of early cART in the gut during acute HIV infection Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection.Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation.An Immunological Perspective on Neonatal Sepsis.Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy.Residual inflammation and viral reservoirs: alliance against an HIV cure.Targeting the gastrointestinal tract to develop novel therapies for HIV.Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand.Clinical and public health implications of acute and early HIV detection and treatment: a scoping review.Post-Treatment Controllers: Role in HIV "Cure" Research.Paediatric HIV infection: the potential for cure.

P2860

Q26748743-941E6ECA-4207-44AC-BA89-D7B555871AA0 Q27316093-96E7861A-58C6-440F-B2DA-DFFB3EFA125F Q28079656-5B81EC35-D4AD-4450-9BDF-19948C5CBD22 Q28552729-283FA2FB-D030-4ADD-B004-84369DC5A5BE Q30248286-33F28DB0-B52C-4969-BD21-6A450F0534FB Q30490195-85094692-CB19-4EF0-8B58-81B812F7AE8D Q30839904-F60DA439-35A2-47EB-8AF5-7765AC1C9789 Q33697163-31D26E91-4253-44D5-8D03-F08D5EB83495 Q35626699-05A13290-7D2B-49CC-B7F7-E92661461F9F Q35769177-237D7A95-DEF8-4C08-8549-35377A776DCA Q35795271-32264CBE-5FD7-4D40-A83A-49CC6C2512A7 Q35872112-CAFC0ED8-B4EA-4BE1-B689-561E9EBE23BE Q36047903-D15F020B-C415-4367-AA0E-BF254F201C2F Q36087130-D87D999D-97B1-440A-9FA5-BFFB0FDA3D45 Q36132003-D46B68A9-7D39-445B-A4FB-37B1B182F759 Q36171153-E3071294-3E78-4887-9B81-32C350E6B428 Q36185114-42277071-E68C-4A6C-A0ED-18341D967C59 Q36274030-57B7C0C1-134A-4A5F-A9F5-45D9BCAC7C04 Q36364264-77AAA76A-E5D1-4FF8-9989-C4D41F1BC03C Q36509593-14A230EE-8AF4-4D6F-92E1-842A1D0AE4E3 Q36539990-FAFD4455-E988-48B6-9FF7-EA73EC871694 Q36553805-104F7610-AF18-4BF8-A2FC-FEF64B6193D5 Q36581887-DF13AF3A-8AA5-4AC5-8967-77908F181981 Q36680086-EF763B55-08B3-4A3A-BFEC-BD08D921294A Q36739989-4E7077AC-5A23-4522-AFA6-03AE110D2ED7 Q37099969-A688CE30-16BC-4F04-B589-F61DC006377B Q37109215-03C4C609-0F91-40B9-945B-4ED135DB38AA Q37182624-9467362E-E1A0-46F4-A823-3665E0BC39F8 Q37182674-E0CAF267-82BF-474A-8780-36B32B08702F Q37234729-61133127-1550-4347-B17D-0ADE71782E8A Q37262786-B15078AE-2B42-4B07-B345-4CDB1363333F Q37407684-DBEA879C-7A2A-4549-968B-C6EFE537681E Q37415771-D48713A1-9687-4AB7-B95A-883CBDF1A322 Q37461290-451A7D84-3D50-4AE4-843E-C2EEAECD2A4A Q38269458-FA30C727-91A3-40A9-A941-E08F12FF284E Q38548095-05AECB7A-0CA2-4F9F-9FD5-F9CFF9F9373A Q38660440-E87B4972-7DCA-49A8-A60D-E742BE86ED4B Q38686953-3659B258-24CA-49FB-88A0-D8C7C5C85406 Q38701493-4B4D595B-A880-4082-B4E7-5DE59E79C9FD Q38773102-5BA145D2-C957-4877-9C4B-DBCC3D271DD4

P2860

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation

http://www.wikidata.org/entity/Q34682171

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Initiation of ART during early ...... HIV-related immune activation

@ast

Initiation of ART during early ...... HIV-related immune activation

@en

Initiation of ART during early ...... HIV-related immune activation

@nl

type

label

Initiation of ART during early ...... HIV-related immune activation

@ast

Initiation of ART during early ...... HIV-related immune activation

@en

Initiation of ART during early ...... HIV-related immune activation

@nl

prefLabel

Initiation of ART during early ...... HIV-related immune activation

@ast

Initiation of ART during early ...... HIV-related immune activation

@en

Initiation of ART during early ...... HIV-related immune activation

@nl

P1433

Q34682171-7365C762-57A8-42AE-9CCE-4AE851C66D89

P1476

Q34682171-5A08236E-CC18-4E0D-961D-600CA787E721

P2093

Q34682171-1A1C81C2-EA4D-42BD-8D17-481E6F5DA9B3

Q34682171-1BCC036B-2423-43E8-833F-0B51D8D4C226

Q34682171-2BD9F1CD-7330-4544-9C4E-4CC6C41CDA79

Q34682171-3388E6E5-595E-4127-94AD-B1C3BB4DB655

Q34682171-3E587673-55BF-4B4B-B85F-C43179650E53

Q34682171-46BEA537-3334-408D-B26A-357BB785794F

Q34682171-4EE04811-DA4D-4AD2-93A4-9449470C5834

Q34682171-59115FE2-AF16-4EC5-8162-9680A098FED2

Q34682171-5BB4E042-5D82-449F-9D87-BAE13C5C38BA

Q34682171-5EA281C1-B77E-4721-82DA-EB96B046A8BB

P2860

Q34682171-009D52A1-C5DA-4FA1-81CA-E9615DC2FE24

Q34682171-00ADA1F4-E49D-443F-A913-1D61CDA6D4C1

Q34682171-0199F5E6-2916-4691-8E85-E6369CEB6083

Q34682171-0405E24F-4128-4A13-8F75-53AADE54188F

Q34682171-070805ED-7432-444E-A828-E018227C7FA3

Q34682171-0C68AF83-0FEC-4BE6-80AF-02F43247BA67

Q34682171-145151A9-6E42-402F-860E-731953E84675

Q34682171-1824F810-F1E9-4909-A74A-796DEC0296A6

Q34682171-196EFAB8-45D5-4097-8020-89E00A346C5C

Q34682171-1F97A467-0551-47F0-9747-520E1D6A2B5C

P304

Q34682171-95CEDE69-1C02-4FD1-AD68-9050D13139FF

P31

Q34682171-E191CF4B-909C-4183-80F3-557FBA4BEEC3

P356

Q34682171-93F68834-9633-4F39-81A2-DEF205C72146

P433

Q34682171-0E6880F8-8B73-42DC-BF17-FE24D1666AF7

P478

Q34682171-29FB53A9-768F-4F2D-9325-D42AEC546FFE

P50

Q34682171-0BA919C5-B538-4EB8-A8CF-7F065040C35B

Q34682171-36BDF80F-7160-422E-96E0-57861C40D1CF

Q34682171-397E7BE2-2C61-41B9-B2C2-FB12EA6BC330

Q34682171-576D5DE8-6B89-42F2-9F74-F937216EA987

Q34682171-9679897F-05E0-4ECF-A4FC-A64CD7CBE4CB

Q34682171-A5A4A48D-E4D1-4472-B6CC-011025B143DB

Q34682171-D2A92C97-A994-433B-8947-745FC7F98B8B

P577

Q34682171-F2966C89-4361-4865-B604-2F41DD829C6A

P5875

Q34682171-4852BA08-4B62-487D-8636-DEAAC54FF9F8

P698

Q34682171-1FF24F6C-6D70-4390-8D5C-69541BCB81E2

P932

Q34682171-460B9255-E1F6-46D7-B583-A9B63DD2D4CD

P356

JOURNAL.PPAT.1004543

P1433

P1476

Initiation of ART during early ...... HIV-related immune activation

@en

P2093

Alexandra Schuetz

http://www.w3.org/2001/XMLSchema#string

Claire Deleage

http://www.w3.org/2001/XMLSchema#string

Daniel C Douek

http://www.w3.org/2001/XMLSchema#string

Eugene Kroon

http://www.w3.org/2001/XMLSchema#string

Jacob D Estes

http://www.w3.org/2001/XMLSchema#string

James L K Fletscher

http://www.w3.org/2001/XMLSchema#string

Mark S de Souza

http://www.w3.org/2001/XMLSchema#string

Mary Marovich

http://www.w3.org/2001/XMLSchema#string

Nitiya Chomchey

http://www.w3.org/2001/XMLSchema#string

Nittaya Phanuphak

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging concepts in the immunopathogenesis of AIDS

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection

IL-22 increases the innate immunity of tissues

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.

P304

e1004543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1004543

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Netanya G. Sandler

Jean-Louis Excler

Jintanat Ananworanich

P577

2014-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269517076

http://www.w3.org/2001/XMLSchema#string

P698

25503054

http://www.w3.org/2001/XMLSchema#string

P932

4263756

http://www.w3.org/2001/XMLSchema#string